Improvement in cardiometabolic risk markers following a multifunctional diet is associated with gut microbial taxa in healthy overweight and obese subjects
Open Access
- 2 November 2017
- journal article
- research article
- Published by Springer Nature in European Journal of Nutrition
- Vol. 57 (8) , 2927-2936
Abstract
Purpose A multifunctional diet (MFD) targeting subclinical inflammation was developed as a tool to decrease risk factors for cardiometabolic disease in healthy “at-risk” individuals (BMI 25–33 kg/m2). MFD contains several components that are degraded in the colon by the microbiota, such as dietary fibers from rye, barley, oats and berries. It also contains soy beans, oily fish and plant stanols. In previous studies, we have observed improved cardiometabolic markers in healthy at-risk individuals after 4–8 week intake of MFD. However, whether these improvements can be associated with changes in the gut microbiota composition has not been investigated. In the present study, we analyzed the gut microbiota before and after an 8-week dietary intervention with MFD. Methods Cardiometabolic at-risk individuals (n = 47), between 51 and 72 years old and with a BMI of 25–33 kg/m2, were given either the MFD or a control diet lacking the functional (“active”) components for 8 weeks in a parallel, randomized design. Next-generation sequencing of bacterial 16S rRNA genes was used to analyze the gut microbiota composition. Results The 8-week intervention with MFD did not significantly alter the gut microbiota composition at phylum or genus taxonomic levels, while LEfSE analysis identified increased abundance of Prevotella copri in the MFD group as compared to the control group. Treponema correlated positively with blood pressure. In contrast, Faecalibacterium showed a negative association with blood pressure, while Bilophila appeared to associate with a negative blood lipid profile. Conclusions Taken together, results from the present study may be used in the further development of effective dietary concepts capable of reducing cardiometabolic risk markers in humans through a targeted modulation of the gut microbial community. Trial registration number Clinical Trials.gov NCT02148653.Keywords
Funding Information
- Antidiabetic Food Centre (2013/55)
This publication has 52 references indexed in Scilit:
- Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− miceNature, 2012
- Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic DiseasesExperimental Diabetes Research, 2012
- A diet based on multiple functional concepts improves cardiometabolic risk parameters in healthy subjectsNutrition & Metabolism, 2012
- Linking Long-Term Dietary Patterns with Gut Microbial EnterotypesScience, 2011
- Metagenomic biomarker discovery and explanationGenome Biology, 2011
- Search and clustering orders of magnitude faster than BLASTBioinformatics, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial TaxonomyApplied and Environmental Microbiology, 2007
- Human gut microbes associated with obesityNature, 2006
- Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARBApplied and Environmental Microbiology, 2006